6055 (6055) Fair Value & Analysis

Consumer Defensive · Market cap HK$13.9B

6 6055 6055 · HK

PriceHK$20.04

Fair ValueHK$24.09

Upside+20.2%

Quality49/100

Watch 6055 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$18.07 – HK$39.82

Fair value as of: Jul 2, 2026

From 26 valuation models · updated today

Share price −19.8% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$18.88 – HK$46.48 · fair‑value band HK$18.07 – HK$39.82 · the HK$20.04 price screens below the HK$24.09 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

6055 (6055) currently trades at HK$20.04, while our model-based Fair Value estimate is HK$24.09 — implying the stock looks roughly 20.2% undervalued today. We read business quality at 49/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 6055 generated revenue of HK$14.6B at a net margin of 6.7%. Revenue declined 2.5% year over year. It earns a return on equity of 29.8%. Net debt stands at HK$2.5B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$14.6B

Revenue growth (YoY) -2.5%

Net margin 6.7%

Return on equity 29.8%

Free cash flow HK$1.0B FY2025

P/E ratio 14.2

More key figures

Operating margin 10.2%

EPS (TTM) HK$1.02

Dividend yield 2.7%

EPS growth (YoY) +30.2%

Net debt HK$2.5B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

6055 reported revenue of HK$14.6B in FY2025 versus HK$8.1B in FY2021, a compound +16.0%/yr. Reported net income was HK$980M in FY2025, compounding +8.7%/yr from FY2021.

Revenue +16.0%/yr

FY21 HK$8.1B

FY22 HK$8.3B

FY23 HK$11.8B

FY24 HK$13.1B

FY25 HK$14.6B

Net income +8.7%/yr

FY21 HK$703M

FY22 HK$375M

FY23 HK$599M

FY24 HK$854M

FY25 HK$980M

Is 6055 fairly valued? → Check now

Similar stocks

6 more Tobacco stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Philip Morris International Inc PM	$173.17	$106.19	-39%
British American Tobacco p.l.c. BTI	$61.12	$31.95	-48%
MO MO	1,253 MXN	1,090 MXN	-13%
Altria Group PHM7	€62.44	€83.69	+34%
Japan Tobacco Inc JAPAF	$34.75	$26.18	-25%
ITC Limited ITC	₹291.25	₹291.49	+0%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 6055 (6055) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$24.09 versus a price of HK$20.04 — about +20% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 6055?

Our model-based fair value for 6055 is HK$24.09 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$20.04.

What is the quality score of 6055?

6055 has a Quality Score of 49/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 6055 (6055)?

6055 reported trailing-twelve-month revenue of about HK$14.6B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 6055?

The net profit margin of 6055 is about 6.7%, meaning it keeps roughly 6.7% of revenue as net income. Based on the latest reported figures.

Does 6055 pay a dividend?

6055 currently shows a dividend yield of about 2.71% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.